KK
PLSE icon

KLP Kapitalforvaltning’s Pulse Biosciences PLSE Stock Holding History

KLP Kapitalforvaltning’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Hold
4,300
– – ﹤0.01% 2045
2026
Q1 		$92.8K Hold
4,300
– – ﹤0.01% 2069
2025
Q4 		$59K Sell
4,300
-1,600
-27% -$24.9K ﹤0.01% 2140
2025
Q3 		$104K Buy
5,900
+3,400
+136% +$53.8K ﹤0.01% 2056
2025
Q2 		$37.7K Hold
2,500
– – ﹤0.01% 2175
2025
Q1 		$40.2K Hold
2,500
– – ﹤0.01% 2212
2024
Q4 		$43.5K Buy
+2,500
New +$44.1K ﹤0.01% 2252

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

KLP Kapitalforvaltning's PLSE Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 4,300 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

KLP Kapitalforvaltning first reported a position in PLSE in Q4 2024 and has held it in 7 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • KLP Kapitalforvaltning held 4,300 shares of Pulse Biosciences worth $119K as of Q2 2026.
  • KLP Kapitalforvaltning left its Pulse Biosciences share count unchanged in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2045 holding.
  • KLP Kapitalforvaltning first reported a position in Pulse Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.